Exploring potential of quinoxaline moiety

International Journal of PharmTech Research

Volumn 3, Issue 1, 2011, Pages 386-392

  Patidar, Ashutosh Kumar ^a   Jeyakandan, M ^a   Mobiya, Ashok Kumar ^a   Selvam, G ^a  

^a Dr Shri RMS Institute of Science and Technology   (India)

Author keywords

Benzopyrazine; Biological activities; Quinoxaline

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; ANTIOXIDANT; ANTIVIRUS AGENT; ANXIOLYTIC AGENT; MONOAMINE OXIDASE A INHIBITOR; PYRROLO[3,4 B]QUINOXALINE; QUINOXALINE; THIENO[2,3 D]PYRIMIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIDEPRESSANT ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; DRUG ACTIVITY; DRUG SYNTHESIS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MICROWAVE IRRADIATION; NONHUMAN; POLYMERIZATION; VIRUS REPLICATION;

EID: 79951570018     PISSN: None     EISSN: 09744304     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Ganapaty S., Ramalingam P. and Rao C.B., Antibacterial, antifungal and antitubercular screening of some novel condensed bridgehead nitrogen heterocycles of quinoxalines, Indian. J. Heterocycl. Chem., 2007,16,283-286.
2. Refaat H.M., Moneer A.A. and Khalil O.M., Synthesis and antimicrobial activity of certain novel quinoxalines, Arch. Phram. Res., 2004,27,1093-1098.
3. Badran M.M., Abouzid K.A.M. and Hussein M.H.M., Synthesis of certain substituted quinoxalines as anti-microbial agents, Part II. Arch. Pharm. Res., 2003,26,107-113.
4. Nasr M.N.A., Synthesis and antibacterial activity of fused 1,2,4- triazolo[4,3-a]quinoxaline and oxopyrimido[2',1':5,1]-1,2,4- triazolo[4,3-a]-quinoxaline derivatives, Arch. Pharm. Med. Chem., 2002, 8,389-394.
5. El-Hawash S.A., Habib N.S. and Fanaki N.H., Quinoxaline derivatives Part II: Synthesis and antimicrobial testing of 1,2,4-triazolo[4,3-a]quinoxalines, 1,2,4-triazino[4,3-a]-quinoxalines and 2-pyrazolylquinoxalines, Pharmazie.,1999,54,808-815.
6. El-Gendy A.A., El-Meligie S., El-Ansary A. and Ahmedy A.M., Synthesis of some quinoxaline derivatives containing indoline-2,3-dione or thiazolidine residue as potential antimicrobial agents, Arch. Pharm. Res., 1995,18,44-47.
7. Tandon V.K., Yadav D.B., Maurya H.K., haturvedi A.K. and Shukla P.K. Design, synthesis and biological evaluation of 1,2,3-trisubstituted-1,4- dihydrobenzo [g] quinoxaline-5,10-diones and related compounds as antifungal and antibacterial agents, Bioorg. Med. Chem., 2006,14,6120-1626.
8. Sanna P., Carta A., Loriga M., Zanetti S., Sechi L., Preparation and biological evaluation of 6/7-trifluoromethyl(nitro)-6,7-difluoro-3-alkyl(aryl)-substituted-quinoxalin-2-ones, Part 3: II Farmaco., 1999,54,1169-1177.
9. Carta A., Sanna P., Gherardini., Usai D., and Zanetti S., Novel functionalized pyrido[2,3-9]- quinoxalinones as antibacterial, antifungal and anticancer agents, II Farmaco., 2001,56, 933-938.
10. Sanna P., Carta A., Loriga M., Zanetti S., and Sechi L., Synthesis of 3,6,7-substitutedquinoxalin-2-ones for evaluation of antimicrobial and anticancer activity. Part 2: II, Farmaco., 1999,54,161-168.
11. Monge A., Martinez-Crespo F.J., Cerain A.L., Palop J.A., Narro S., Senador V., Marin A., Sainz Y., Gonzalez M., Hamilton E. and Barker A.J., Hypoxia-selective agents derived from 2-quinoxaline carbonitrile 1,2- di-N-oxides 2, J. Med. Chem.,1995,38, 4488-4494.
12. Jaso A., Zarranz B., Aldana I., and Monge A., Synthesis of new 2-acetyl and 2-benzoylquinoxaline 1,4-di-N-oxide derivatives as antimycobacterium tuberculosis agents, Eur. J. Med. Chem., 2003,38,791-800.
13. Guillon J., Forfar I., Matsuda M.M., Desplat V., Saliege M. and Thiolat D., Synthesis, analytical behavior and biological evaluation of new 4-substituted pyrrolo[1,2-a]quinoxalines as antileishmanial agents, Bioorg. Med. Chem. Lett., 2007,15,194-210.
14. Rangisetty J.B., Gupta C.N.V.H.B., Prasad A.L., Srinivas P., Sridhar N., Parimoo P. and Veeranjaneyulu A., Synthesis of new arylaminoquinoxalines and their antimalarial activity in mice, J. Pharmacy and Pharmacology.,2001,53,1409-1413.
15. Crowther A.F., Curd F.H.S., Davey D.G. and Stacey G.J., Synthetic antimalarials, Part XXXIX Dialkylaminoalkyl-aminoquinoxalines, J. Chem. Soc.,1949,1260-1262.
16. Hassan S.Y., Khattab S.N., Bekhit A.A. and Amer A., Synthesis of 3-benzyl-2-substituted quinoxalines as novel monoamine oxidase A inhibitors, Bioorg. Med. Chem. Lett.,2006, 16(6),1753-1756.
17. Sarges R., Howard H.R., Browne R.G., Lebel L.A., Seymour P.A. and Koe B.K., 4- Amino[1,2,4]triazolo[4,3-a]quinoxalines. A novel class of potent adenosine receptor antagonists and potential rapid-onset antidepressants, J. Med. Chem.,1990,33,2240-2254.
18. Ali M.M., Ismail M.M.F., El-Gaby M.S.A., Zahran M.A. and Ammar Y.A., Synthesis and antimicrobial activities of some novel quinoxalinone derivatives, Molecules.,2000,5,864-873.
19. Obafemi C.A. and Akinpelu D.A., Synthesis and antimicrobial activity of some 2(1H)- quinoxalinone-6-sulfonyl derivatives. Phosphorus, Sulfur, Silicon, Relat. Elem., 2005,180,1795-1807.
20. Ries U.J., Priekpe H.W., Havel N.H., Handschuh S., Mihm G., Stassen J.M., Wienen W., and Nar H., Heterocyclic thrombin inhibitors. Part 2: quinoxalinone derivatives as novel, potent antithrombotic agents, Bioorg. Med. Chem. Lett., 2003,13,2297-2302.
21. Wendt G.R. and Ledig K.W., 6,7-Dihydroxy-1Hpyrazolo[3,4- 6]quinoxaline-5,8-diones.U.S. Patent, 3,431,262, Chem. Abstr.,1969,70,106512.
22. Su D.S. and Bock M.G., 2-Quinoxalinone derivatives as bradykinin antagonists and novel Compounds, US Patent. Appl., 2005, (20050020591).
23. Esther V., Pablo R., Duchowicz B., Eduardo A., Castro A., and Antonio M., QSAR analysis for quinoxaline-2-carboxylate 1,4-di-N-oxides as anti-mycobacterial agents J. Mol. Graph. Model., 2009,28,28-36.
24. Staszewska A., Stefanowicz P. and Szewczuk Z., Direct solid-phase synthesis of Quinoxaline containing peptides, Tetrahedron. Lett.,2005,46,5525-5528.
25. Srinivas C., Kumar C.N.S.P., Rao V.J. and Palaniappan S. Green approach for the synthesis of quinoxaline derivatives in water medium using reusable polyaniline sulfate salt catalyst and sodium laurylsulfate, Catal. Lett., 2008, 121,29-296.
26. Gupta R.R., Kumar M. and Gupta V., Heterocyclic Chemistry, Springer Publication,1998,1, 13-14.
27. Bansal R.K. Heterocyclic chemistry. 3rd ed. New Age Internation Pvt. Ltd., 2005,464-472.
28. Thakuria H. and Das G., One-pot efficient geeen synthesis of 1,4-dihydroquinoxaline-2,3-dione derivatives, J. Chem. Sci., 2006,118(5),425-428.
29. Gris J., Glisoni R., Fabian L., Fernandez B. and Moglioni A.G., Synthesis of potential chemotherapic quinoxalinone derivatives by biocatalysis or microwave-assisted Hinserg reaction, Tetrahedron Lett.,2008,49,1053-1056.
30. Rostamizadeh S. and Jafari S. The synthesis of quinoxalines under microwave Irradiation, Indian. J. Heterocycl. Chem.,2001,10,303-304.
31. Heravi M.M., Bakhtiari K., Tehrani M.H., Javadi N.M. and Oskooie H.A., Facile synthesis of quinoxaline derivatives using o-iodoxybenzoic acid (IBX) at room temperature, General Papers ARKIVOC, 2006, XVI,16-22.
32. Lin S.K., A facile synthesis of quinoxaline-2,3-diones as NMDA receptor antagonists, Molecules,1996,1,37-40.
33. Cai J.J., Zou J.P., Pan X.Q. and Zhang W. Gallium triflate catalyzed synthesis of quinoxaline derivatives, Tetrahedron Lett.,2008,49,7386-7390.
34. Bhosale R.S., Sarda S.R., Ardhapure S.S., Jadhav W.N., Bhusare S.R. and Pawar R.P., An efficient protocol for the synthesis of quinoxaline derivatives at room temperature using molecular iodine as the catalyst, Tetrahedron. Lett.,2005,46,6345-6348.
35. Ammar Y.A., Ismail M.M.F., El-Gaby M.S.A. and Zahran M.A., Some reactions with quinoxaline-2,3-dicarboxylic acid anhydride: Novel synthesis of thieno[2,3-d]pyrimidines and pyrrolo[3,4-b]quinoxalines as antimicrobial agents. Indian. J. Chem., 2002, 41B, 1486-1491.
36. Pawar P.Y. and Bhise S.B., Synthesis of 6,7-Bis[(2-substituted Phenyl)-4-oxo-thiazolidin- 3-yl)]quinoxaline-2,3-(1H,4H)-diones asantitubercular agents, J. Pharm. Res., 2008, 7(4),226-228.
37. Venugopalan B., Suresh S., Karnik P.J. and Souza N.J., Synthesis and antiamoebic activity of 2,3-diaryl-5,8-dimethoxyquinoxalines, Indian. J. Chem.,1991,30B,777-783.
38. Hassan S.Y., Khattab S.N., Bekhit A.A. and Amer A., Synthesis of 3-benzyl-2-substituted quinoxalines as novel monoamine oxidase A inhibitors. Bioorg. Med. Chem. Lett., 2006,16(6),1753-1756.
39. Sandra P., Quinoxaline Chemistry, Synthesis of Methyl [4-(Substituted 2-quinoxalinyloxy) Phenyl] acetate and evaluation of anticancer activity, II FARMCO, 2004,59,185-194.
40. Asuncion B., Synthesis and antiinflammatory/antioxidant activities of some new ring substituted 3-phenyl-1-(1, 4-di-N-oxide quinoxaline-2-yl)-2-propen-1-one derivative, Bioorg. Med. Chem. Lett.,2007,17,6439-6443.